Search
news › new-tool-improves-gene-identification
… of Dr. Huda Zoghbi , which studies neurological diseases. One of the lab’s goals is to identify modifier genes that … contributed to this work. The authors are affiliated with one or more of the following institutions: Baylor College of …
healthcare › ... › diagnostic-testing-for-inflammatory-bowel-disease
… Please visit our clinical trials page for more information. …
healthcare › ... › infusion-center
… Center offers patients an easy, attractive alternative to a hospital setting for receiving their infusion therapy, simplifying and … care and treatment. We provide patients and their families comprehensive infusion services in a comfortable, private … of infusion, include: Chemotherapy Biological immune modulators Hematologic growth factors Injectable hormonal therapy …
news › targeting-tgf-b-for-treatment-of-osteogenesis-imperfecta
… examined human bone samples from OI patients at consortium sites at Baylor/Texas Children’s Hospital and the University … TGF-β in a Phase 1 clinical trial conducted at BBDC sites at Baylor and Oregon Health & Science University. …
healthcare › ... › for-patients
… Please visit our central patient information page for information …
news › baylor-recruiting-participants-for-covid-19-prevalence-study
… the study will set up facilities at the different sites and randomly ask individuals to participate in testing … the month of July, the study will recruit at the following sites in Houston: Discovery Green, 1500 McKinney St Jamail …
departments › ... › admissions
… a picture of the department as is possible in a short visit. … CST Register for Menninger/BCM Psychiatry Open House 2025-2026 … You may begin the application process by going to the ERAS site . Three letters of recommendation must be submitted via … accepting PGY-II transfer applications for academic year 26-27. Please check back in fall 2026 regarding the …
news › getting-to-the-heart-of-glp-1
… health, and it might not all be related to weight loss alone. GLP-1 medications, including semaglutide, are a class … recognizes excess and dysfunctional adipose (fat) tissue as one of the key drivers of cardiovascular disease. “Adipose … passive; it functions as an endocrine organ, releasing hormones that communicate with the body, including the …
healthcare › ... › for-patients
… service, privacy practices (HIPAA), and forms including general health, Authorization for Release of Protected … General Information …
news › promising-results-for-hyperlipidemia-treatment-reduces-risk-of-cardiovascular-events
… and cholesterol. The results, published in the latest edition of the New England Journal of Medicine , …